Charles Schwab Investment Management Inc Kymera Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 366,841 shares of KYMR stock, worth $15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
366,841
Previous 375,101 2.2%
Holding current value
$15 Million
Previous $11.2 Million 55.07%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$30.16 - $52.4 $249,121 - $432,824
-8,260 Reduced 2.2%
366,841 $17.4 Million
Q2 2024

Aug 12, 2024
BUY
$29.85 - $39.42 $626,700 - $827,622
20,995 Added 5.93%
375,101 $11.2 Million
Q1 2024

May 08, 2024
BUY
$22.9 - $43.57 $1.09 Million - $2.07 Million
47,414 Added 15.46%
354,106 $14.2 Million
Q4 2023

Feb 06, 2024
BUY
$10.97 - $26.84 $54,312 - $132,884
4,951 Added 1.64%
306,692 $7.81 Million
Q3 2023

Nov 08, 2023
BUY
$13.9 - $23.88 $8,882 - $15,259
639 Added 0.21%
301,741 $4.19 Million
Q2 2023

Aug 09, 2023
BUY
$22.4 - $34.92 $58,351 - $90,966
2,605 Added 0.87%
301,102 $6.92 Million
Q1 2023

May 11, 2023
BUY
$24.84 - $38.75 $14,630 - $22,823
589 Added 0.2%
298,497 $8.84 Million
Q4 2022

Feb 13, 2023
BUY
$19.57 - $30.92 $378,640 - $598,240
19,348 Added 6.95%
297,908 $7.44 Million
Q3 2022

Nov 14, 2022
BUY
$20.91 - $34.27 $460,396 - $754,556
22,018 Added 8.58%
278,560 $6.07 Million
Q2 2022

Aug 15, 2022
BUY
$14.13 - $42.55 $17,874 - $53,825
1,265 Added 0.5%
256,542 $5.05 Million
Q1 2022

May 13, 2022
BUY
$35.3 - $64.68 $238,027 - $436,137
6,743 Added 2.71%
255,277 $10.8 Million
Q4 2021

Feb 11, 2022
BUY
$49.91 - $65.56 $264,972 - $348,058
5,309 Added 2.18%
248,534 $15.8 Million
Q3 2021

Nov 16, 2021
BUY
$47.8 - $66.66 $6.65 Million - $9.28 Million
139,149 Added 133.7%
243,225 $14.3 Million
Q2 2021

Aug 16, 2021
BUY
$31.08 - $51.95 $1.29 Million - $2.16 Million
41,628 Added 66.66%
104,076 $5.05 Million
Q1 2021

May 17, 2021
BUY
$35.64 - $85.46 $39,702 - $95,202
1,114 Added 1.82%
62,448 $2.43 Million
Q4 2020

Feb 16, 2021
BUY
$28.07 - $87.83 $1.72 Million - $5.39 Million
61,334 New
61,334 $3.8 Million

Others Institutions Holding KYMR

# of Institutions
184
Shares Held
64.4M
Call Options Held
50.6K
Put Options Held
81.7K
View Full List

About Kymera Therapeutics, Inc.

KYMR Quotes by TradingView
  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.23B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email